Predicting toxicity and response to pembrolizumab (P) through germline genomic HLA class I analysis

Authors :: Pamela S. Ohashi
Sevan Hakgor
Stephanie Lheureux
Trevor J. Pugh
Vinod Chandran
Marco A. J. Iafolla
Albiruni Ryan Abdul Razak
Cindy Yang
Melania Pintilie
P. Bedard
L.L. Siu
Aaron R. Hansen
Anna Spreafico
Amanda Giesler
Source :: Annals of Oncology. 29:viii29
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
business.industry
Toxicity
Cancer research
Medicine
Hematology
Pembrolizumab
Human leukocyte antigen
business
Class (biology)
Germline

Full Text Access

Tools